ADVFN - Advanced Financial Network.
HOME» NYSE » J » JNJ Stock Price » JNJ Stock News

Johnson & Johnson Share News

 Johnson & Johnson Stock Price
JNJ Stock Price
 Johnson & Johnson Stock Chart
JNJ Stock Chart
 Johnson & Johnson Stock News
JNJ Stock News
 Johnson & Johnson Company Information
JNJ Company Information
 Johnson & Johnson Stock Trades
JNJ Stock Trades

J&J CEO: Will Make Any Changes Needed After Recall

DOW JONES NEWSWIRES Johnson & Johnson's (JNJ) chief executive vowed to make whatever changes are needed for its manufacturing processes to meet consumers' expectations and the company's own standards, saying it has hired independent quality experts to help. The company recalled about 1,500 lots of bottled products last week, including pediatric versions of Tylenol, Motrin, Zyrtec and Benadryl. Its McNeil Consumer Healthcare unit said it was withdrawing the over-the-counter products, starting late last Friday, because of manufacturing problems at its Fort Washington, Pa., plant In an open letter Friday to all those who use J&J products on the firm's corporate blog, Chairman and Chief Executive Bill Weldon called the recalls a disappointment to him and the rest of the company and its workers. "I have been assured that the chance of a serious medical event from the recalled products is remote," he said. "Even so, this does not give us comfort; one of our companies has let you down." He reiterated that McNeil suspended manufacturing at the Pennsylvania plant and has hired independent quality experts to help the facility return to the proper standards and also reevaluate the systems and manufacturing processes across the organization. He ended the note by saying the company "will work hard to earn back your confidence." A House committee said earlier this week it is opening an investigation into conflicting accounts of what had prompted the recall, as well as how the company handled consumer complaints about foreign matter in the bottles. Johnson & Johnson shares were up 0.2% at $63.42 in after-hours trading. The stock is down modestly so far this year. Johnson & Johnson blog: -By Joan E. Solsman, Dow Jones Newswires; 212-416-2291;

Stock News for Johnson & Johnson (JNJ)
09/03/201509:00:00Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare...
08/27/201517:28:00Johnson & Johnson to Participate in the 2015 Wells Fargo 10th...
08/25/201519:18:00Splenda Sweetener Getting a New Owner
08/25/201516:00:00Heartland Food Products to Buy Splenda From J&J Unit
08/25/201515:42:00Heartland Food Products to Buy Splenda From J&J Unit
08/12/201507:30:15Reckitt Benckiser Gets U.K. Approval to Buy K-Y Lubricants
08/12/201504:46:18Reckitt Benckiser Gets U.K. Regulatory Approval to Buy K-Y Lubricants
08/10/201512:50:48Statement of Changes in Beneficial Ownership (4)
08/10/201507:50:20Mallinckrodt to Buy Immunotherapy Firm Therakos
08/06/201510:30:05IBM Adds to Its Watson Health Service
08/03/201513:20:20Depomed to File Injunction Against Pursuer Horizon
07/31/201516:32:51Quarterly Report (10-q)
07/21/201513:36:28Horizon Boosts Depomed Bid to About $2 Billion
07/20/201511:40:00Johnson & Johnson Announces Quarterly Dividend for Third Quarter...
07/15/201514:44:373 Questions Johnson & Johnson's Second-Quarter Results Answered
07/14/201514:30:44J&J Lifts Earnings Outlook Despite Stronger Dollar, Competition--3rd...
07/14/201509:59:02Johnson & Johnson Sees Better Times Ahead Despite Dollar-Driven...
07/14/201509:39:23J&J Lifts Earnings Outlook Despite Stronger Dollar, Competition--2nd...
07/14/201509:14:36Correction to J&J Lifts Earnings Outlook Story
07/14/201508:55:50J&J Lifts Earnings Outlook Despite Stronger Dollar, Competition--Update

Johnson & Johnson and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations